FDA’s Compounding Oversight: What Price Safety?
As meningitis outbreak widens, FDA and members of Congress are calling for clarification of what jurisdiction the agency has over pharmacies, but agency officials are stopping short of asking for clear new authorities.
You may also be interested in...
Millions of epidural steroid injections are done off label for pain every year in America, but in some cases at the cost of paralysis, stroke or even death; FDA’s Anesthetic and Analgesic Drug Products Advisory Committee will consider labeling changes on Nov. 25.
HHS and other stakeholders largely praise the work of industry’s Rx Response as a single point of contact for the government and pharmaceutical industry to address pharmaceutical supply chain challenges during Super Storm Sandy.
The long-time head of CDER’s Office of Regulatory Policy will become senior advisor to center Director Janet Woodcock in charge of pharmacy compounding issues effective Jan. 6.